🇪🇸 Spain Country × Condition
advanced solid tumor Clinical Trials in Spain
Active clinical trials for advanced solid tumor with research sites in Spain. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇪🇸 Spain
Active Trials in Spain (4)
NCT07128303 Phase 1
Recruiting
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
Enrollment
476 pts
Country
🇪🇸 Spain
Gilead Sciences
View Trial → NCT05547321 Phase 1
Recruiting
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Enrollment
150 pts
Country
🇪🇸 Spain
Oncomatryx Biopharma S.L.
View Trial → NCT07629960 Phase 1, Phase 2
Recruiting
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Enrollment
265 pts
Country
🇪🇸 Spain
Blueprint Medicines Corporation
View Trial → NCT05765851 Phase 1
Recruiting
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
Enrollment
128 pts
Country
🇪🇸 Spain
Daiichi Sankyo
View Trial → Frequently Asked Questions
How many advanced solid tumor clinical trials are active in Spain?
There are currently 4 active clinical trials for advanced solid tumor with sites in Spain, of which 4 are actively recruiting patients.
How can I join a advanced solid tumor clinical trial in Spain?
To join a advanced solid tumor clinical trial in Spain, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Spain directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are advanced solid tumor trials in Spain?
Active advanced solid tumor trials in Spain span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology